Andrea Vaclavkova

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study

Ludwig Kappos, Robert J. Fox, Michel Burcklen et al. · JAMA Neurology · 2021 · 218 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +8

Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial

Andrea Vaclavkova, Sergio Chimenti, Petr Arenberger et al. · The Lancet · 2014 · 148 citations

Dentistry, Pharmacotherapy, Oral Medicine In Older Adults +5

Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis

Mark S. Freedman, Carlo Pozzilli, Eva Havrdová et al. · Neurology · 2022 · 20 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +13

Mitigation of Initial Cardiodynamic Effects of the S1P₁ Receptor Modulator Ponesimod Using a Novel Up‐Titration Regimen

Pierre‐Éric Juif, Matthias Hoch, Andrea Vaclavkova et al. · The Journal of Clinical Pharmacology · 2016 · 17 citations

Medicine, Pharmacology, Pharmacotherapy +12

Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P1 Receptor Modulator in Healthy Subjects

Pierre‐Éric Juif, Daniela Baldoni, Maribel Reyes et al. · International Journal of Molecular Sciences · 2017 · 17 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15